Effexor XR Price and Availability across Vendors - in the UK

Executive summary

Venlafaxine extended-release, commonly known by the brand Effexor XR or as generic MR/XL venlafaxine, is an antidepressant classified as an SNRI (serotonin-noradrenaline reuptake inhibitor). In the UK you will encounter modified-release capsules labelled as MR or XL; these are formulated to discharge active drug gradually to maintain steadier plasma levels than immediate-release forms.

This medicine is used primarily for depressive episodes and several anxiety-related disorders. For the conditions it treats see the section This is for whom. Important safety topics are described under Interactions between parties and Monitoring and precautionary guidelines.

Go back to the very top

Active ingredient of the formulation

Venlafaxine is the principal active ingredient. It acts by reducing the reuptake of serotonin and noradrenaline in the brain, increasing their availability in pathways that influence mood and anxiety. Modified-release capsules are typically bead-filled and should be swallowed whole; opening, crushing or chewing disrupts the release the mechanism at stake and can increase deleterious effects. Practical dosing information is available in How to withstand it.

Jump to content the high point of the page

This solution is for whom

In UK practice venlafaxine MR is considered for a range of mental health conditions, often when first-line options have not achieved adequate benefit or are not tolerated. Frequent manifestations include:

• The diagnosis of major depressive disorder
• Chronic excessive worry characterises generalised anxiety disorder
• The anxiety disorder called panic disorder
• Some cases of social anxiety disorder

Choice of treatment is personalised. Psychological therapies such as cognitive behavioural therapy are frequently offered either before or alongside medication. Off-label uses should only be guided by a specialist. For non-venlafaxine options see Similar medications and an additional choice choices.

Return to the start page top

On hand strengths

Common modified-release strengths available in the UK include:

• 37.5 mg per dose MR
• 75 mg MR
• 150 mg MR

Doses are adjusted to the individual. Clinicians usually start at a low dose and increase gradually. Higher daily doses are often reached by combining capsules of different strengths. For advice on starting, increasing or tapering a regimen refer to Ways to handle it and Awareness and safety protocols.

Take me to the topmost level of the page

How to weather it

• Take your venlafaxine once each day, preferably at the same time to maintain stable levels. Taking with food can reduce stomach upset.
• Swallow capsules whole with water; do not open, split, crush or chew MR/XL capsules.
• Implement the prescription exactly as directed. Do not stop suddenly; a gradual dose reduction is usually recommended to reduce withdrawal effects.
• Use in people under 18 should involve specialist input and careful follow up.

If you notice new or worsening mood changes after starting or changing the dose contact the prescriber promptly. If a dose is not taken at the planned time, refer to the i did not take a dose this section. Dose not given. Confirm the file contents training for overdose incident prevention and response. OD event.

Take me to the high point of the page

When a dose is missed

If you remember shortly after the dose was omitted, take it. If the next scheduled dose is approaching, skip the dose was omitted and continue as normal; do not take two doses to make up. If in doubt contact your pharmacist or prescriber for advice.

Return to the earlier section the page top

Drug taking an overdose scenario

If you suspect an non fatal overdose seek urgent medical help by calling 999 or attend the nearest emergency department. For less severe symptoms ring NHS 111 for advice. Keep the medicine container with you. Signs of serious non fatal overdose can include agitation, severe drowsiness, vomiting, fast or irregular heartbeat, seizures, breathing problems, or marked blood pressure changes.

Head to the leading position of the page

Cooperative exchanges

Venlafaxine interacts with a number of medicines, supplements and herbal products. Always give your clinician an up to date list of everything you are taking, including over-the-counter items. Combining serotonergic agents increases the risk of serotonin syndrome; see Negative reactions for red flag symptoms.

Avoid these combinations

• Monoamine oxidase inhibitors (MAOIs) such as phenelzine, tranylcypromine, isocarboxazid, and selegiline, along with the antibiotic linezolid. Allow at least 14 days after stopping an MAOI before starting venlafaxine, and usually 7 days after stopping venlafaxine before beginning an MAOI.
• St John's wort (Hypericum perforatum)
• Tryptophan nutritional supplements
• Nefazodone classed as a SARI antidepressant
• Procarbazine is used in chemotherapy
• Medications specifically for appetite suppression or weight loss
• Other SNRIs such as duloxetine

Use with care and watch for any anomalies.

• Other antidepressants including SSRIs, tricyclics, mirtazapine, and vortioxetine
• Triptans for migraine (for example sumatriptan, rizatriptan, zolmitriptan)
• Stimulants such as amphetamine or methylphenidate
• Tramadol is an analgesic and other opioids with serotonergic action
• Anticoagulants, antiplatelets and NSAIDs (risk of bleeding)
• Medicines that influence heart rhythm and blood pressure
• Some antipsychotics, cimetidine, certain antivirals including ritonavir
• Strong CYP2D6 inhibitors such as paroxetine or fluoxetine
• Buspirone or lithium which may amplify serotonergic effects

If you develop fever, shaking, agitation, confusion, muscle stiffness, or rapid heart rate seek urgent medical attention as these may indicate serotonin syndrome. For more on system monitoring see Continuous observation and safety measures.

Move to top

Before you begin the process

Tell your prescriber if any of the following apply to you:

• Uncontrolled hypertension, heart disease or recent myocardial infarction
• Prior history of bipolar affective disorder with mania or hypomania
• Eye disorders such as glaucoma or unexplained visual symptoms
• Impaired hepatic or renal function
• History of convulsions or epileptic disorder
• Current or past suicidal thoughts or self harm
• Previous low sodium levels or diuretic use (risk of hyponatraemia)
• Pathology of the thyroid
• High cholesterol or active lipid treatment
• Eating disorders or significant weight loss
• Allergy to venlafaxine or related antidepressants
• If you are pregnant, considering conceiving, or breastfeeding

Venlafaxine is prescribed only for the person named on the prescription. Do not share your medicine.

Go to top

Continuous observation and safety measures

• Benefits may take 2 to 4 weeks to appear; full effect can take longer. Keep scheduled reviews to assess response and adverse effects.
• Venlafaxine can elevate blood pressure and heart rate, particularly at higher doses. Blood pressure checks are commonly performed after dose changes.
• Watch for changes in mood or behaviour. Worsening depression, suicidal thoughts, increased agitation or impulsivity warrant urgent review.
• Loss of balance sensation, drowsiness or blurred vision can occur. Avoid driving or operating machinery until you know how the medicine affects you. Beverage with ethanol may increase drowsiness and is best avoided.
• Older adults and people on diuretics may develop hyponatraemia; seek advice for confusion, skull ache or unsteadiness.
• Dry mouth is common; drinking water and sugar free gum can help.
• Long term use may affect lipid levels; clinicians may consider periodic cholesterol checks.
• Do not stop venlafaxine abruptly. Withdrawal symptoms such as dizziness, flu-like symptoms, irritability, insomnia and sensory disturbances are possible; gradual tapering reduces risk.
• Ask a pharmacist before taking cough, cold or allergy medicines as some can interact.

Go back to the pinnacle of the page

Possible reactions to the medication

If you notice any changes, seek medical attention urgently.

• Severe allergic reactions: rash, swelling of face, lips or tongue, or hives
• Breathing trouble or severe chest symptoms
• Eye pain, sudden vision changes or halos around lights
• Hallucinations, extreme agitation or losing touch with reality
• Seizure occurrences
• New or growing thoughts of ending one's life or behaviours
• Marked difficulty passing urine
• Unexpected bleeding or bruising
• Symptoms of serotonin syndrome such as high fever, sweating, tremor, confusion or muscle rigidity

Common byproducts that often improve with time

• Nausea, upset stomach or reduced appetite
• Uncontrolled sweating or flushing
• Infrequent defecation with discomfort or dry mouth
• Tremor, pain in the head, dizziness or sleep disturbances
• Reduced sexual drive or sexual dysfunction
• Weight change, often weight loss initially

This list does not include everything. If undesired effects persist or are troublesome contact your prescriber or pharmacist. For the exchange between people-related effects see Interplay between individuals.

Return to the start the first place

Storing and disposing of items

• Store where children cannot see or reach it.
• Store in a cool, dry place below 25 degrees C, away from heat and moisture.
• Keep capsules in their original container until needed.
• Do not use after the expiry date on the label.
• Return unwanted or expired medicine to a pharmacy; do not throw it in household waste or pour it down the sink.

Return to the start top

Similar therapies and substitute medicines

Depending on individual circumstances, clinicians may recommend other possible paths. These include:

• Selective serotonin reuptake inhibitors (SSRIs): sertraline, citalopram, escitalopram, fluoxetine and paroxetine are commonly used first-line for depression and many anxiety disorders.
• Other SNRIs: duloxetine may be chosen when coexisting pain symptoms are relevant.
• Different antidepressant classes: mirtazapine (useful for insomnia or low appetite), vortioxetine (may help cognitive symptoms), tricyclics such as amitriptyline or clomipramine for selected cases, and moclobemide under specialist supervision.
• Non-drug options: cognitive behavioural therapy, counselling, lifestyle changes and social support are effective either alone or with medication.
• Condition-specific medicines: for example, pregabalin may be considered for generalised anxiety disorder in some situations.

Price and availability vary. Generic SSRIs and generic venlafaxine are usually cheaper than brand names. When switching between antidepressants be aware of required washout intervals and safety risks in the act of connecting with others; see Conversational the networked exchange of ideass between people can shape outcomes. and tapering advice and steps under Vigilant safety and status monitoring practices steps.

Jump forward to the topmost level of the page

Standard price framework in the United Kingdom

Costs vary between pharmacies and whether you receive medication via the NHS or privately. Approximate private prices for a 28 to 30 day supply (generic venlafaxine MR) are:

• the dosage is 37.5 mg MR: around GBP 3 to GBP 8
• 75 mg MR: around GBP 4 to GBP 12
• 150 mg MR: around GBP 6 to GBP 15

Private online clinics and pharmacies may charge additional consultation or dispensing fees, making total monthly costs roughly GBP 10 to GBP 30. On the NHS: in England most patients pay a per item prescription charge unless exempt or covered by a prepayment certificate; in Scotland, Wales and Northern Ireland NHS prescriptions are generally free at the point of dispensing. Branded Effexor XR is typically more expensive than generics.

For comparison, many generic SSRIs such as sertraline or citalopram commonly cost about GBP 1 to GBP 6 per month privately before provider fees. Mirtazapine prescription often costs around GBP 2 to GBP 6, and duloxetine around GBP 3 to GBP 10 depending on strength and supplier.

Jump ahead to top

UK regulatory information and access resources

• Status: venlafaxine is a prescription only medicine (POM) in the UK. It is not a controlled drug. A valid prescription from a UK-registered prescriber is required for supply.
• Prescribing and surveillance of system activity: it is not always used first-line. Clinicians assess individual risks and benefits and may monitor blood pressure and other parameters during treatment.
• Online supply: use pharmacies registered with the General Pharmaceutical Council (GPhC). Look for a GPhC registration number besides the MHRA distance selling logo on the provider's website.
• Import for personal use: the Medicines and Healthcare products Regulatory Agency (MHRA) permits limited personal imports. Quantities larger than a small personal supply (commonly interpreted as up to three months) may attract customs scrutiny.
• Driving and safety: do not drive or operate heavy machinery if you feel impaired. Driving while unfit due to a medicine can be an offence.
• Gestation and nursing: discuss risks and benefits with your clinician before starting or stopping treatment.
• Juveniles and adolescents: prescribing for those under 18 should involve specialist input and close continuous oversight.
• Electronic prescriptions and repeats: the Electronic Prescription Service (EPS) is widely used in the NHS; repeat prescriptions still require clinical oversight.
• You can report suspected adverse reactions through the MHRA Yellow Card scheme.
• Travel: carry medicines in original packaging and keep a copy of your prescription when travelling abroad.

For regulated services check the GPhC register or the NHS website. In an emergency contact 999; for urgent concerns about adverse effects ring NHS 111.

Return to this point atop

Be aware

This page is intended to provide general information and does not replace personalised medical advice. Always follow the directions of your own clinician and consult the Patient Information Leaflet supplied with your medicine. If you are unsure about anything contact your prescriber or pharmacist.

Move back to the top tier